ONC

NASDAQStock

BeOne Medicines Ltd.

$288.00-10.99 (-3.68%)

52-Week Range

$206.32
$377.47

Key Stats

Market Cap

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.52

Volume

198.6K

Avg Volume

331.7K

Performance

1M

-19.28%

3M

-10.58%

6M

-14.14%

YTD

-8.27%

1Y

+14.19%

3Y

+57.78%

5Y

+57.78%

Price Chart

ETF Exposure

ONC is held by 21 ETFs

ETFFund NameWeight
FBTFirst Trust NYSE Arca Biotechnology Index Fund3.23%
BBHVanEck Biotech ETF3.13%
AGNGGlobal X - Aging Population ETF2.40%
IBBiShares Biotechnology ETF1.92%
CANCTema Oncology ETF1.73%
EMEQMacquarie Focused Emerging Markets Equity ETF0.98%
EEMOInvesco S&P Emerging Markets Momentum ETF0.78%
CGGECapital Group Global Equity ETF0.64%
BIBProShares - Ultra Nasdaq Biotechnology0.50%
CGIECapital Group International Equity ETF0.50%
HELXFranklin Genomic Advancements ETF0.29%
SPWOSP Funds S&P World (ex-US) ETF0.27%
CGNGCapital Group New Geography Equity ETF0.26%
NTSEWisdomTree Emerging Markets Efficient Core Fund0.17%
TNXTT. Rowe Price Innovation Leaders ETF0.11%
DFSEDimensional - Emerging Markets Sustainability Core 1 ETF0.08%
DFAEDimensional - Emerging Core Equity Market ETF0.04%
DFEMDimensional - Emerging Markets Core Equity 2 ETF0.03%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.02%
PXFInvesco RAFI Developed Markets ex-U.S. ETF0.01%
DFAXDimensional - World ex US Core Equity 2 ETF0.01%

About ONC ETF Exposure

BeOne Medicines Ltd. (ONC) is held by 21 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $288.00. Investors can gain exposure to ONC through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ONC, sorted by portfolio weight.